The most common concerns we treat include weight gain, insomnia, fatigue, hot flashes, mood changes, sexual concerns, brain fog, and unexplained pain
This table outlines critical biomarkers and monitoring intervals that help providers track safety and efficacy in this population
A recent Wall Street Journal article explores how recreational athletes, including runners, cyclists, and triathletes, are increasingly using GLP-1 medications to enhance performance by reducing body weight, improving endurance, and accelerating recovery
Finally, GIPr agonism may decrease the nauseating effects of GLP-1 agonism through area postrema inhibitory neurons potentially allowing for higher therapeutic doses of GLP-1 analogs with decreased adverse effects [13]
As a class effect of GLP-1 receptor agonists, gallbladder disease including cholelithiasis has been reported, particularly in the context of rapid weight loss
I always leave feeling empowered and accomplished